Longevity Health Inc. (XAGE)
Longevity Health Statistics
Share Statistics
Longevity Health has 30.12M shares outstanding. The number of shares has increased by 46.44% in one year.
| Shares Outstanding | 30.12M |
| Shares Change (YoY) | 46.44% |
| Shares Change (QoQ) | 44.08% |
| Owned by Institutions (%) | n/a |
| Shares Floating | 26.72M |
| Failed to Deliver (FTD) Shares | 7.19K |
| FTD / Avg. Volume | 0.11% |
Short Selling Information
The latest short interest is 115.61K, so 0.38% of the outstanding shares have been sold short.
| Short Interest | 115.61K |
| Short % of Shares Out | 0.38% |
| Short % of Float | 0.46% |
| Short Ratio (days to cover) | 1 |
Valuation Ratios
The PE ratio is 0 and the forward PE ratio is null. Longevity Health's PEG ratio is 0.
| PE Ratio | 0 |
| Forward PE | n/a |
| PS Ratio | 0 |
| Forward PS | null |
| PB Ratio | 0 |
| P/FCF Ratio | 0 |
| PEG Ratio | 0 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for Longevity Health.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.16, with a Debt / Equity ratio of -0.14.
| Current Ratio | 0.16 |
| Quick Ratio | 0.14 |
| Debt / Equity | -0.14 |
| Debt / EBITDA | -0.06 |
| Debt / FCF | -0.15 |
| Interest Coverage | -101.98 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | $3.35K |
| Profits Per Employee | $-691.22K |
| Employee Count | 15 |
| Asset Turnover | 0.03 |
| Inventory Turnover | 0.06 |
Taxes
| Income Tax | -97.28K |
| Effective Tax Rate | 0.91% |
Stock Price Statistics
The stock price has increased by -92.89% in the last 52 weeks. The beta is 0.76, so Longevity Health's price volatility has been higher than the market average.
| Beta | 0.76 |
| 52-Week Price Change | -92.89% |
| 50-Day Moving Average | 0.21 |
| 200-Day Moving Average | 0.49 |
| Relative Strength Index (RSI) | 46.37 |
| Average Volume (20 Days) | 6.39M |
Income Statement
In the last 12 months, Longevity Health had revenue of 50.32K and earned -10.37M in profits. Earnings per share was 0.
| Revenue | 50.32K |
| Gross Profit | 43.96K |
| Operating Income | -5M |
| Net Income | -10.37M |
| EBITDA | -10.5M |
| EBIT | -10.7M |
| Earnings Per Share (EPS) | 0 |
Balance Sheet
The company has 157.14K in cash and 638.99K in debt, giving a net cash position of -481.85K.
| Cash & Cash Equivalents | 157.14K |
| Total Debt | 638.99K |
| Net Cash | -481.85K |
| Retained Earnings | -68.87M |
| Total Assets | 1.47M |
| Working Capital | -4.92M |
Cash Flow
In the last 12 months, operating cash flow was -4.39M and capital expenditures 0, giving a free cash flow of -4.39M.
| Operating Cash Flow | -4.39M |
| Capital Expenditures | 0 |
| Free Cash Flow | -4.39M |
| FCF Per Share | 0 |
Margins
Gross margin is 87.37%, with operating and profit margins of -9933.82% and -20605.47%.
| Gross Margin | 87.37% |
| Operating Margin | -9933.82% |
| Pretax Margin | -21359.64% |
| Profit Margin | -20605.47% |
| EBITDA Margin | -20870.2% |
| EBIT Margin | -9933.82% |
| FCF Margin | -8722.42% |
Dividends & Yields
XAGE does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | n/a |
| FCF Yield | n/a |
Analyst Forecast
Currently there are no analyst rating for XAGE.
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
Scores
| Altman Z-Score | -92.74 |
| Piotroski F-Score | 4 |